Join
Live feed
·
PRReleasevia Quantisnow
Kiromic BioPharma Inc. logo

Kiromic BioPharma Reports Patient 4 in Deltacel-01 Clinical Trial Reaches 10-Month Progression-Free Survival

ByQuantisnow·Wall Street's wire, on your screen.
KRBP· Kiromic BioPharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRBP (Kiromic BioPharma Inc.) and more on Quantisnow.